Expression of c-sis and other cellular proto-oncogenes in human sarcoma cell lines and biopsies - PubMed
- ️Sun Jan 01 1989
Comparative Study
. 1989 Oct 15;44(4):652-7.
doi: 10.1002/ijc.2910440416.
Affiliations
- PMID: 2793239
- DOI: 10.1002/ijc.2910440416
Comparative Study
Expression of c-sis and other cellular proto-oncogenes in human sarcoma cell lines and biopsies
C Fahrer et al. Int J Cancer. 1989.
Abstract
Six biopsies (4 of human fibrosarcomas, 1 of a B-cell lymphoma and 1 of a normal lymph node from a melanoma patient) and 6 cell lines (derived from 5 different human osteosarcomas and from 1 rhabdomyosarcoma), together with control cells, were examined for the expression of c-sis, c-fos and c-myc. The expression of c-sis/PDGF-B-related proteins was also examined in cultured cells (not in biopsies). In situ hybridization studies further showed that the occurrence and level of expression of c-sis mRNA and c-sis/PDGF-B-related proteins were significant in the tumor cells. Expression of c-fos and c-myc mRNA did not correlate with c-sis expression. Southern blot analysis of c-sis, c-fos and c-myc of 20 DNAs of cell lines derived from human sarcoma or biopsies showed an identical pattern for BamH1 and EcoR1 restriction fragments of c-sis (except for 1 fibrosarcoma biopsy), implicating no gene rearrangement as a cause of enhanced proto-oncogene expression. The nucleotide sequence of c-sis is highly homologous to that of the viral v-sis oncogene which is capable of transforming infected cells. We conclude that enhanced expression of c-sis in the sarcomas we have examined is involved in the initiation and/or maintenance of the cell transformed state.
Similar articles
-
Genomic alterations in sarcomas: a histologic correlative study with use of oncogene panels.
Maillet MW, Robinson RA, Burgart LJ. Maillet MW, et al. Mod Pathol. 1992 Jul;5(4):410-4. Mod Pathol. 1992. PMID: 1495946
-
Kiefer PE, Wegmann B, Bacher M, Erbil C, Heidtmann H, Havemann K. Kiefer PE, et al. J Cancer Res Clin Oncol. 1990;116(1):29-37. doi: 10.1007/BF01612637. J Cancer Res Clin Oncol. 1990. PMID: 1690210
-
Husain Z, FitzGerald GB, Wick MM. Husain Z, et al. J Invest Dermatol. 1990 Nov;95(5):571-5. doi: 10.1111/1523-1747.ep12505549. J Invest Dermatol. 1990. PMID: 2121834
-
The molecular genetics of soft tissue sarcomas.
Knight JC. Knight JC. Eur J Cancer. 1990 Apr;26(4):511-3. doi: 10.1016/0277-5379(90)90027-q. Eur J Cancer. 1990. PMID: 2141519 Review. No abstract available.
Cited by
-
Signals controlling the expression of PDGF.
Dirks RP, Bloemers HP. Dirks RP, et al. Mol Biol Rep. 1995-1996;22(1):1-24. doi: 10.1007/BF00996300. Mol Biol Rep. 1995. PMID: 8858568 Review.
-
Scotlandi K, Baldini N, Oliviero M, Di Renzo MF, Martano M, Serra M, Manara MC, Comoglio PM, Ferracini R. Scotlandi K, et al. Am J Pathol. 1996 Oct;149(4):1209-19. Am J Pathol. 1996. PMID: 8863670 Free PMC article.
-
Smits A, Funa K, Vassbotn FS, Beausang-Linder M, af Ekenstam F, Heldin CH, Westermark B, Nistér M. Smits A, et al. Am J Pathol. 1992 Mar;140(3):639-48. Am J Pathol. 1992. PMID: 1372158 Free PMC article.
-
Chemotherapy for metastatic soft tissue sarcomas--another full circle?
Bramwell VH. Bramwell VH. Br J Cancer. 1991 Jul;64(1):7-9. doi: 10.1038/bjc.1991.230. Br J Cancer. 1991. PMID: 1854630 Free PMC article. Review. No abstract available.
-
Molecular targets in therapy for human soft-tissue and bone sarcomas.
Steinert DM, Blakely LJ, Salganick J, Trent JC. Steinert DM, et al. Curr Oncol Rep. 2003 Jul;5(4):295-303. doi: 10.1007/s11912-003-0069-8. Curr Oncol Rep. 2003. PMID: 12781071 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical